Adherence to omalizumab: a real-life study

被引:0
|
作者
Campisi, Raffaele [1 ]
Crimi, Claudia [1 ]
Noto, Alberto [2 ]
Foschino, Maria Pia [3 ]
Valenti, Giuseppe [4 ]
Viviano, Vittorio [4 ]
Pelaia, Corrado [5 ]
Ricciardi, Luisa [6 ]
Scichilone, Nicola [7 ]
Crimi, Nunzio [8 ]
机构
[1] AOU Policlin Vittorio Emanuele, Resp Med Unit, Catania, Italy
[2] AOU Policin G Martino, Anesthesia & Intens Care Unit, Messina, Italy
[3] Univ Foggia, Inst Resp Dis, Dept Med & Surg Sci, Foggia, Italy
[4] Ctr Individuato ASMA GRAVE, Ctr Riferimento Aziendale Terr Prevenz Malattie A, Palermo, Italy
[5] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, Italy
[6] Univ Messina, Sch & Div Allergy & Clin Immunol, Dept Human Pathol, Messina, Italy
[7] Univ Palermo, Sez Pneumol, Dipartimento Biomed Med Interna & Specialist DIBI, Palermo, Italy
[8] Univ Catania, Resp Med Unit, Dept Clin & Expt Med, AOU Policlin Vittorio Emanuele, Catania, Italy
关键词
Asthma; -; management; Quality of life; Adherence;
D O I
10.1183/13993003.congress-2019.PA2525
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
PA2525
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Effectiveness of Omalizumab in Severe Allergic Asthma and Nasal Polyposis: A Real-Life Study
    Tiotiu, A.
    Oster, J. P.
    Roux, P. R.
    Nguyen Thi, P. L.
    Peiffer, G.
    Bonniaud, P.
    Daiphin, J. C.
    de Blay, F.
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2020, 30 (01) : 49 - 57
  • [22] Long-term evaluation of response to omalizumab therapy in real life by a novel multimodular approach The Real-life Effectiveness of Omalizumab Therapy (REALITY) study
    Singh, Harjinder
    Peters, Jay, I
    Kaur, Yogeet
    Maselli, Diego J.
    Diaz, Joseph D.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (05) : 476 - +
  • [23] Real-Life Effects of Omalizumab on Chronic Rhinosinusitis with Nasal Polyposis
    Lombardo, Nicola
    Piazzetta, Giovanna Lucia
    Lobello, Nadia
    Cicala, Giuseppe
    Patafi, Maria
    Benincasa, Anna Teresa
    Pelaia, Corrado
    Chiarella, Emanuela
    Pelaia, Girolamo
    Kim, Dong-Kyu
    JOURNAL OF PERSONALIZED MEDICINE, 2024, 14 (01):
  • [24] Omalizumab in Chronic Spontaneous Urticaria: A Brazilian Real-Life Experience
    Ensina, Luis Felipe
    Rodrigues Valle, Solange Oliveira
    Juliani, Ana Paula
    Galeane, Michel
    dos Santos, Rosaly Vieira
    Arruda, Luisa Karla
    Lima Melo, Janaina Michelle
    de Souza, Patricia Karla
    Serpa, Faradiba Sarquis
    de Andrade, Djanira Martins
    Franca, Alfeu Tavares
    Campos, Regis Albuquerque
    Camelo-Nunes, Ines
    Sole, Dirceu
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2016, 169 (02) : 121 - 124
  • [25] Omalizumab under 12 years old: Real-life practice
    Pite, H.
    Gaspar, A.
    Paiva, M.
    Leiria-Pinto, R.
    ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2013, 41 (02) : 133 - 136
  • [26] Predictive factors of recurrence after omalizumab cessation in the elderly with urticaria: A real-life study
    Oztop, Nida
    Demir, Semra
    Unal, Derya
    Beyaz, Sengul
    Terzioglu, Kadriye
    Olgac, Muge
    Gelincik, Asli
    ALLERGY AND ASTHMA PROCEEDINGS, 2022, 43 (06) : 519 - 528
  • [27] Patterns of clinical use of omalizumab in Spain: A 5-year "real-life" study
    de Llano, Luis Perez
    Zubeldia, Jose Manuel
    Herraez, Lys
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [28] "Real-life" effectiveness of omalizumab in patients with severe persistent allergic asthma: The PERSIST study
    Brusselle, G.
    Michils, A.
    Louis, R.
    Dupont, L.
    de Maele, B. Van
    Delobbe, A.
    Pilette, C.
    Lee, C. S.
    Gurdain, S.
    Vancayzeele, S.
    Lecomte, P.
    Hermans, C.
    MacDonald, K.
    Song, M.
    Abraham, I.
    RESPIRATORY MEDICINE, 2009, 103 (11) : 1633 - 1642
  • [29] Adherence to Subcutaneous Allergen Immunotherapy in Southeast Turkey: A Real-Life Study
    Tat, Tugba S.
    MEDICAL SCIENCE MONITOR, 2018, 24 : 8977 - 8983
  • [30] Adherence to omalizumab: A multicenter "real-world" study
    Campisi, Raffaele
    Crimi, Claudia
    Intravaia, Rossella
    Strano, Simona
    Noto, Alberto
    Foschino, Maria Pia
    Valenti, Giuseppe
    Viviano, Vittorio
    Pelaia, Corrado
    Ricciardi, Luisa
    Scichilone, Nicola
    Crimi, Nunzio
    WORLD ALLERGY ORGANIZATION JOURNAL, 2020, 13 (02):